| Cryptococcus neoformans A Casadevall, JR Perfect ASM press, 1998 | 1458 | 1998 |
| Misconduct accounts for the majority of retracted scientific publications FC Fang, RG Steen, A Casadevall Proceedings of the National Academy of Sciences 109 (42), 17028-17033, 2012 | 1427 | 2012 |
| Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi L Brown, JM Wolf, R Prados-Rosales, A Casadevall Nature Reviews Microbiology 13 (10), 620-630, 2015 | 1392 | 2015 |
| The convalescent sera option for containing COVID-19 A Casadevall, L Pirofski The Journal of clinical investigation 130 (4), 1545-1548, 2020 | 1227 | 2020 |
| Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity A Casadevall, L Pirofski Infection and immunity 67 (8), 3703-3713, 1999 | 1017 | 1999 |
| Deployment of convalescent plasma for the prevention and treatment of COVID-19 EM Bloch, S Shoham, A Casadevall, BS Sachais, B Shaz, JL Winters, ... The Journal of clinical investigation 130 (6), 2757-2765, 2020 | 975 | 2020 |
| Synthesis and assembly of fungal melanin HC Eisenman, A Casadevall Applied microbiology and biotechnology 93, 931-940, 2012 | 825 | 2012 |
| The contribution of melanin to microbial pathogenesis JD Nosanchuk, A Casadevall Cellular microbiology 5 (4), 203-223, 2003 | 785 | 2003 |
| Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease A Casadevall, L Pirofski Infection and immunity 68 (12), 6511-6518, 2000 | 736 | 2000 |
| The damage-response framework of microbial pathogenesis A Casadevall, L Pirofski Nature Reviews Microbiology 1 (1), 17-24, 2003 | 732 | 2003 |
| Passive antibody therapy for infectious diseases A Casadevall, E Dadachova, L Pirofski Nature Reviews Microbiology 2 (9), 695-703, 2004 | 709 | 2004 |
| Urease as a virulence factor in experimental cryptococcosis GM Cox, J Mukherjee, GT Cole, A Casadevall, JR Perfect Infection and immunity 68 (2), 443-448, 2000 | 648 | 2000 |
| Cryptococcus neoformans var.grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates SP Franzot, IF Salkin, A Casadevall Journal of clinical microbiology 37 (3), 838-840, 1999 | 639 | 1999 |
| Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence ML Rodrigues, ES Nakayasu, DL Oliveira, L Nimrichter, JD Nosanchuk, ... Eukaryotic cell 7 (1), 58-67, 2008 | 627 | 2008 |
| Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages JN Steenbergen, HA Shuman, A Casadevall Proceedings of the National Academy of Sciences 98 (26), 15245-15250, 2001 | 604 | 2001 |
| Convalescent plasma antibody levels and the risk of death from Covid-19 MJ Joyner, RE Carter, JW Senefeld, SA Klassen, JR Mills, PW Johnson, ... New England Journal of Medicine 384 (11), 1015-1027, 2021 | 603 | 2021 |
| Host‐pathogen interactions: the attributes of virulence A Casadevall, L Pirofski The Journal of infectious diseases 184 (3), 337-344, 2001 | 598 | 2001 |
| Ionizing radiation changes the electronic properties of melanin and enhances the growth of melanized fungi E Dadachova, RA Bryan, X Huang, T Moadel, AD Schweitzer, P Aisen, ... PloS one 2 (5), e457, 2007 | 595 | 2007 |
| The capsule of the fungal pathogen Cryptococcus neoformans O Zaragoza, ML Rodrigues, M De Jesus, S Frases, E Dadachova, ... Advances in applied microbiology 68, 133-216, 2009 | 583 | 2009 |
| Cryptococcosis JR Perfect, A Casadevall Infectious Disease Clinics 16 (4), 837-874, 2002 | 574 | 2002 |
